Application 213349
- Type
- ANDA
- Sponsor
- AJANTA PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
| 002 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 003 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 10MG BASE | No | No |
| 004 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213349-001 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | ||
| A213349-002 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | ||
| A213349-003 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | ||
| A213349-004 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213349-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2022-03-31 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213349-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2022-03-31 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213349-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2022-03-31 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213349-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2022-03-31 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213349-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213349-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213349-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213349-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A213349-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A213349-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A213349-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A213349-004 | AB | 1 | 5d02ea3f76ae… |
| 2022-09-29 23:25 UTC | 2022-09 | A213349-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A213349-002 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A213349-003 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A213349-004 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213349-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213349-002 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213349-003 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213349-004 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| nebivolol | NEBIVOLOL HYDROCHLORIDE | AvKARE | 1ce89dc5-018d-db40-e063-6294a90a9722 | 2026-01-16 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| nebivolol | NEBIVOLOL HYDROCHLORIDE | Apnar Pharma LP | 3f5766c0-e1fa-4805-a32c-523182310ad5 | 2025-02-14 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| Bystolic | NEBIVOLOL HYDROCHLORIDE | Allergan, Inc. | 8b8ad213-1dc8-454e-a524-075685c0e1a8 | 2024-08-01 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| nebivolol | NEBIVOLOL HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | cb47560d-9e35-4b0f-b12b-6ea478684a5b | 2023-08-01 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| Nebivolol Hydrochloride | NEBIVOLOL HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | b1762bbb-b5be-48a7-8101-bb736f28845a | 2023-07-11 | Warnings, Adverse reactions | Nebivolol Hydrochloride NEBIVOLOL HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 27241-179 | Nebivolol | Nebivolol | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-180 | Nebivolol | Nebivolol | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-181 | Nebivolol | Nebivolol | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-182 | Nebivolol | Nebivolol | Ajanta Pharma USA Inc. | ANDA | Current |